CD4 and AIDS: Eligibility for ART has been heavily reliant on HIV/AIDS clinical staging criteria,1,2 but we and others have shown that this is a poor indicator of immunosuppression.3,4 There has been a steady increase in the use of CD4+ T-lymphocyte enumeration (CD4 counting) by flow cytometry to guide clinical decision-making in the management of HIV infection in Africa.